Nicotine is a naturally occurring tobacco alkaloid classified chemically as a tertiary amine alkaloid and pharmacologically as a stimulant. It acts primarily as a nicotinic acetylcholine receptor (nAChR) agonist, meaning it stimulates specific receptors in the nervous system that regulate neurotransmitter release and neural signaling. Functionally, nicotine behaves as a ganglionic stimulant and cholinergic agonist, producing sympathomimetic effects such as increased heart rate, alertness, and blood pressure at low doses, while potentially causing depressant effects at higher doses.
To understand nicotine better, we need a deep dive in its delivery formats. The table below shows the trends in nicotine delivery formats.
Nicotine pouches (oral, tobacco-free)
Fastest growing
Very strong growth (high double-digit CAGR)
Discreet use, no smoke/vape, strong youth & adult adoption, aggressive marketing, clean nicotine perception
Heated tobacco products (HTPs)
Rapid growth
Strong growth (low-to-mid double digits)
Tobacco companies shifting to reduced-risk products; strong uptake in Asia/Europe
Vapes/E-cigarettes (overall)
Mixed trend
Slowing or declining in mature markets, still growing in some regions
Regulatory pressure, flavor bans, competition from pouches/HTPs, illicit market growth
Nicotine replacement therapy (gum, patch, lozenge, spray)
Stable
Slow, steady / flat growth
Medical use for quitting smoking; not a lifestyle product
Synthetic nicotine products (vapes & pouches)
Emerging fast
Fast-growing niche
Tobacco-free positioning, regulatory loopholes, innovation in product design
Combustible cigarettes
Declining
Long-term global decline
Health awareness, regulation, taxation, shift to alternatives
Cigars & cigarillos
Slight decline/ Flat
Stable to mild decline
Niche premium consumption, less mass-market appeal
Traditional smokeless tobacco (chewing tobacco, snus in some regions)
Mixed
Declining in many regions, stable in Nordic markets
Regulatory pressure, shift to modern pouches
NRT inhalers/nasal sprays
Very slow decline
Low demand, niche medical use
Replaced by newer cessation methods and lower usage rates
Considering the adverse effects of tobacco consumption, some countries are actively decoding how to phase out the use of tobacco from general public. While public smoking bans are active in several cities, strict bans are still not in place worldwide. New Zealand had implemented generational smoking ban, which banned tobacco sales for future generations. This ban was repealed in 2024, but several countries have implemented strict tobacoo bans. Given below are major tobacco bans worldwide:
Maldives
Generational tobacco ban
Tobacco use/sale for people born on or after Jan 1, 2007; Sale and use of e-cigarettes/vapes (all ages)
Active (world’s strictest recent policy)
Singapore
Near-total functional ban on smoking in public + strict control
Smoking banned in most public places; strict enforcement + no vaping allowed
Active strict control system
Mexico
Very broad public smoking ban
Smoking banned in most indoor and many outdoor public spaces
One of the strictest public bans
UK
Generational tobacco phase-out law
People born after 2009 permanently cannot buy tobacco
Passed, not fully in force yet
France
Outdoor smoking restrictions (partial ban)
Smoking banned in parks, beaches, forests, school areas
Partial restriction
Belgium
Disposable vape ban (nicotine control)
Ban on disposable e-cigarettes
Product-level ban
sales@straitsresearch.com